Registration

With the package of reforms to the regulatory framework for complementary medicines in full swing, Complementary Medicines Australia’s (CMA) regulatory seminar offers delegates the chance to be on the front foot for positive change. CMA are excited to share with you the 2017 Regulatory Obligations Seminar Program offering a learning environment that will be educational and informative with an exceptional lineup of speakers and topics including:

Among the 19 recommendations to improve the regulation of complementary medicines, incentives for innovation, new listing pathways and a comprehensive and streamlined indications list are on the horizon for the sector. Be among the first to hear about the detail of the reforms, as well as the ongoing and future regulatory developments.

We look forward to receiving your registration and welcoming you to our Regulatory Obligations Seminar 2017.

DATE:

11/04/2017

TIME:

08:30 - 17:00

VENUE:

InterContinental Hotel, Double Bay, Sydney

PARKING:

Valet parking is available at the hotel for a flat rate of $50. Alternatively, you may also self-park at Wilsons Parking Double Bay whose entrance is right next to the hotel, or at Woollahra Council's car park at 1 Cross Street, a short 5 minute walk from the hotel.

Program

8:30- 9:00

Registration& Exhibition

9.00- 9.15

Opening Address & Welcome

9.15-10.15

Reforms to the Regulation of Complementary Medicines

The TGA has commenced the implementation process of the Government’s response to the review of Complementary Medicines

Australia Made: Country of Origin Labelling for Complementary Medicines

Implications of the recent passing of the Competition and Consumer Amendment (Country of Origin) Bill 2016.

Ian Harrison

Chief Executive Officer

Australia Made Campaign

1.00 2.00

Lunch break & Exhibition

2:00-

2.30

Low Risk Therapeutic Goods: To Regulate or Not to Regulate

Review of low risk therapeutic goods in a risk based regulatory regime.

How should low risk products be regulated? As a food or therapeutic?

Mark McDonald

Senior Adviser, Regulatory Reforms

Therapeutic Goods Administration

2:30

3.15

Improving Competitiveness and Innovation in Complementary Medicines

Incentivising innovation in the CM sector

Mechanisms for regulatory protection

Speaker Panel including industry perspectives

Lyndall Soper

Assistant Secretary

Therapeutic Goods Administration

TGA speakers

Industry speakers

3:15

Afternoon Tea

3.30
4:45

The Science of Complementary Medicines
Clinical Trials and CM Evidence Based Requirements

Clinical research contributes to improved health by providing new options for prevention and disease management that can be directly integrated into mainstream health practices.
This session will cover the generation of robust evidence for the CM sector as well as potential challenges moving forward with regulatory reform.

Dr Jon Wardle

Head of Regulatory, Policy and Legislative Stream Australian Research Centre in Complementary and Integrative Medicine (ARCCIM)